Antibiotic stewardship in ICU during covid-19

ABSTRACT

Antibiotic resistance rates and illnesses caused by antibiotic-resistant organisms are on the rise. Antimicrobial overuse and misuse, as well as the need to optimize antimicrobial usage, are key contributors to resistance development. Although bacterial coinfection rates were modest in coronavirus illness, antibiotic consumption rates were relatively high. 2019 Antibiotic stewardship programs (ASPs) attempt to improve patient outcomes, reduce hospital costs, and avoid antibiotic resistance by optimizing antimicrobial prescribing patterns. Clinicians may be directed to administer antibiotics based on the presentation of patients with severe coronavirus illness in 2019. Because primary evidence implies that bacterial infection is uncommon in COVID 19, antibiotic selection through COVID 19 may promote antibiotic resistance. As a result, it's critical to keep antimicrobial stewardship initiatives going. The widespread use of antibiotics in the ICU has significant ecological consequences, promoting the spread of multidrug-resistant bacteria (MDRB) in this setting. As a result, the main goals of AMS programs in the ICU are to improve infection control and reduce AMR during the pandemic. Antibiotic resistance rates and illnesses caused by antibiotic-resistant organisms are on the rise. Antimicrobial overuse and misuse, as well as the need to optimize antimicrobial usage, are key contributors to resistance development. The number of people who used antibiotics was extremely significant. © 2021, SILAE (Italo-Latin American Society of Ethnomedicine). All rights reserved.